Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value:
$363.95M
Total Bought:
$26.74M
Total Sold:
$20.45M
Net Transaction:
+$6.30M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)1,131,5001,131,5000$80.39M$80.21M22.04%-$181.0K
UroGen Pharma Ltd.(URGN)1,673,4201,648,420-25,000$61.58M$66.98M18.40%+$5.39M
Puma Biotechnology Inc4,131,2994,131,2990$33.50M$41.02M11.27%+$7.52M
Candel Therapeutics Inc3,497,9483,497,9480$36.03M$36.52M10.03%+$489.7K
Trevi Therapeutics, Inc.(TRVI)2,144,8442,144,8440$40.00M$30.71M8.44%-$9.29M
Helus Pharma Inc.1,540,2661,540,2660$10.18M$18.93M5.20%+$8.75M
Jade Biosceinces Inc986,760986,7600$21.93M$13.86M3.81%-$8.06M
Bicara Therapeutics643,381668,381+25,000$19.10M$12.44M3.42%-$6.66M
Verastem, Inc.(VSTM)1,469,1531,469,1530$5.61M$11.83M3.25%+$6.21M
Onkure Therapeutics IncCL A2,839,6742,839,6740$12.95M$7.75M2.13%-$5.20M
Eugene Therapeutics1,271,2573,811,782+2,540,525$2.20M$7.62M2.09%+$5.42M
An2 Therapeutics01,300,000+1,300,000$0$6.92M1.90%+$6.92M
Aura Biosciences Inc929,0771,025,349+96,272$6.60M$6.44M1.77%-$157.3K
Protara Therapeutics Inc1,752,1151,752,1150$6.69M$5.34M1.47%-$1.35M
Annexon Inc.01,136,974+1,136,974$0$4.81M1.32%+$4.81M
Leonabio, Inc.634,5391,144,416+509,877$5.83M$4.09M1.12%-$1.75M
Whitehawk Therapeutics Inc1,139,363932,139-207,224$5.22M$3.50M0.96%-$1.71M
Q32 Bio Inc.216,171216,1710$2.75M$1.79M0.49%-$966.3K
Karyopharm Therapeutics Inc1,518,1131,222,019-296,094$14.83M$1.49M0.41%-$13.34M
Jasper Therapeutics1,438,1591,438,1590$604.0K$834.1K0.23%+$230.1K
Yarrow Biosciences Inc1,42532,005+30,580$926$720.7K0.20%+$719.8K
Bioatla Inc108,126108,127+1$447.6K$140.6K0.04%-$307.1K
Page 1 of 1
ACORN CAPITAL ADVISORS, LLC — 13F Holdings — Q3 2026 | TickerTrail